Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 5INDUSTRY 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 168Gliosarcoma 134Glioblastoma 130Brain Neoplasms 101Astrocytoma 86Central Nervous System Neoplasms 77Osteosarcoma 65Oligodendroglioma 61Neuroblastoma 58Sarcoma, Kaposi 56Glioma 51Neuroectodermal Tumors, Primitive, Peripheral 48Dendritic Cell Sarcoma, Interdigitating 44Burkitt Lymphoma 44Rhabdomyosarcoma 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Neoplasms 40Lymphoma 39Wilms Tumor 37Medulloblastoma 35Lymphoma, Non-Hodgkin 35Recurrence 32Sarcoma, Ewing 31Acquired Immunodeficiency Syndrome 30Lymphoma, Large B-Cell, Diffuse 29HIV Infections 29Ependymoma 28Leukemia 27Gastrointestinal Stromal Tumors 27Melanoma 26

Interventions

vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × GIST × Sarcoma × Clear all
NCT02015065 2020-03-30

Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled 14 charts
Sarcoma

GIST

Data powered by HemOnc (CC BY 4.0) Colophon âš¡